Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 5.8% Following Analyst Downgrade

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) fell 5.8% during trading on Wednesday after Bank of America downgraded the stock from a buy rating to a neutral rating. Bank of America now has a $25.00 price target on the stock, down from their previous price target of $27.00. Acadia Healthcare traded as low as $22.05 and last traded at $21.94. 280,886 shares traded hands during trading, a decline of 87% from the average session volume of 2,209,954 shares. The stock had previously closed at $23.30.

Other equities analysts have also issued research reports about the company. Mizuho lowered their price target on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, August 13th. Royal Bank Of Canada decreased their target price on Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Stephens raised Acadia Healthcare to a “hold” rating in a research report on Monday, June 2nd. Barclays decreased their target price on Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday, August 7th. Finally, UBS Group decreased their target price on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $39.00.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently made changes to their positions in the company. Orion Porfolio Solutions LLC grew its stake in shares of Acadia Healthcare by 68.8% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 31,479 shares of the company’s stock valued at $714,000 after purchasing an additional 12,831 shares during the period. State of Wyoming grew its stake in shares of Acadia Healthcare by 1,631.1% during the 2nd quarter. State of Wyoming now owns 24,356 shares of the company’s stock valued at $553,000 after purchasing an additional 22,949 shares during the period. Caxton Associates LLP grew its stake in shares of Acadia Healthcare by 1,234.5% during the 2nd quarter. Caxton Associates LLP now owns 173,482 shares of the company’s stock valued at $3,936,000 after purchasing an additional 160,482 shares during the period. FORA Capital LLC grew its stake in shares of Acadia Healthcare by 121.9% during the 2nd quarter. FORA Capital LLC now owns 46,562 shares of the company’s stock valued at $1,056,000 after purchasing an additional 25,582 shares during the period. Finally, Headlands Technologies LLC grew its stake in shares of Acadia Healthcare by 149.4% during the 2nd quarter. Headlands Technologies LLC now owns 64,828 shares of the company’s stock valued at $1,471,000 after purchasing an additional 38,835 shares during the period.

Acadia Healthcare Trading Down 9.6%

The stock has a 50 day moving average of $22.16 and a 200-day moving average of $24.55. The company has a market capitalization of $1.94 billion, a P/E ratio of 13.95, a P/E/G ratio of 4.58 and a beta of 0.89. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.